Life Sciences Product Marketing Must Build for the Buyer Who Never Calls You

Product marketing in life sciences is often measured by the quality of materials that reach known prospects. That metric ignores the majority of the actual buying audience: the researchers, procurement managers, and operations leaders evaluating your solution right now, through digital channels, without your team’s knowledge. The product marketing function that only builds for known contacts is building for a fraction of the people who determine whether your product makes the shortlist.

What should life sciences product marketing teams build to engage buyers who self-educate before any sales contact?

According to Guideflow, interactive demos and self-serve product experiences compress evaluation timelines and capture higher-intent signals than gated content. In life sciences, where products are technically complex and clinical credibility is non-negotiable, an interactive product experience that lets a researcher explore functionality on their terms is a trust-building asset. A gated datasheet is not.

According to Forrester, “Marketing, sales, and customer success teams must all be ready to engage with buyers when they are best positioned to create maximum value.” For life sciences product marketing, this requires building a different kind of asset: not materials for meetings, but environments for exploration — tools a buyer can navigate independently, when your sales team is offline and they are deciding whether to keep you on the shortlist.

The life sciences product marketing teams winning in 2026 are not the ones with the best at-conference materials. They are the ones whose digital buyer experiences survive independent evaluation by a technical committee that never picks up the phone. Kaon’s Demo360 gives product marketing the infrastructure to build that experience — and to make it work across the full spectrum of clinical and operational buyer personas.